Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma (Q45004821)

8 December 2017

title

Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma (English)

1 reference

8 December 2017

1 reference

Guan-Xian Liu

1

1 reference

8 December 2017

Xin Zhang

2

1 reference

8 December 2017

Su Li

3

1 reference

8 December 2017

Richard D Koiiche

4

1 reference

8 December 2017

Jerry H Sindsceii

5

1 reference

8 December 2017

Haihan Song

6

1 reference

8 December 2017

publication date

9 May 2013

1 reference

8 December 2017

1 reference

8 December 2017

volume

34

1 reference

8 December 2017

issue

5

1 reference

8 December 2017

page(s)

2741-2746

1 reference

Molecular characterization of the tumor microenvironment in breast cancer

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Monocyte chemoattractant protein-1 (MCP-1): an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

CCL2 is a potent regulator of prostate cancer cell migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

A CCR2-V64I polymorphism affects stability of CCR2A isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-013-0827-7

C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis.

21 January 2018

1 reference

12 December 2020

Chemotherapy for renal cell carcinoma

1 reference

12 December 2020

A Single Amino Acid Change Converts an Inhibitory Transcription Factor into an Activator

1 reference

12 December 2020

Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma

1 reference

12 December 2020

MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment

1 reference

12 December 2020

A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression

1 reference

12 December 2020

10.1007/S13277-013-0827-7

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1001553794

0 references

1 reference